Support BioEngage’s events and programming with a gift, or by becoming a Sponsor through our Industry Partnership Program.
Make a Gift
With your support, BioEngage can continue to build lasting relationships between UW’s Department of Bioengineering and biomedical industry.
Become a Sponsor – Industry Partnership Program
Seeking to advance your company’s relationship with UW Bioengineering? By sponsoring BioEngage through our Industry Partnership Program, your company is waived of all fees to participate in our events and programs. Membership benefits include:
- Advertisement on our digital and print communications
- Invites to UW BioE/BioEngage events
- Access to online resume books
For an annual fee of $5,000, your company can join the Industry Partnership Program today. Contact for more information:
Associate Director, Corporate Relations, UW College of Engineering
email@example.com | (206)685-0167
We acknowledge BioEngage’s Industry Partnership Program’s Founding Members, Just BioTherapeutics and NanoString Technologies, Inc. for supporting the program in its in inaugural year:
Just Biotherapeutics is an integrated design company focused on technologies that accelerate development of biotherapeutics and substantially reduce their manufacturing cost. Centering on core strengths of molecular design, process and product design, and manufacturing plant design, Just BioTherapeutics aims to catalyze expansion into cost-sensitive markets and create new therapeutic approaches. Working with selected partners and collaborators, Just will deliver lasting value by enabling access to biologics in the global marketplace.
NanoString Technologies, Inc. is a publicly held provider of life science tools for translational research and molecular diagnostics. These technologies enable a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString’s nCounter® Analysis System uses a molecular color-coded barcode technology for the direct, digital and multiplexed measurement of hundreds of unique transcripts in a single reaction. Additionally, with 3D Biology™ capability DNA, RNA and protein can be simultaneously analyzed in a single assay from the same sample.
Intellectual Ventures Laboratory
Intellectual Ventures Laboratory discovers, invents, and develops advanced technology solutions in a wide variety of fields. We focus on the very beginning stages of invention, validating a concept and refining the technology to demonstrate its potential for commercial or humanitarian use.
At the core of our success are broadly interdisciplinary teams, which address pressing technical issues in malaria and tuberculosis diagnostics, vaccine logistics, vector control, agricultural productivity, and more.
EKOS Corporation, a BTG International group company, pioneered the development and clinical application of ultrasound infusion technologies in medicine. It introduced its first system for the treatment of vascular thrombosis (blood clots) in 2005. Since its beginning, EKOS has had one goal: develop life-enhancing and lifesaving treatments for blood clots that occur in arteries and veins. Our endovascular therapies improve patient outcomes, lower risks and improve treatment predictability.
InBios is a leading biotechnology company based in Seattle, Washington (USA). We specialize in the design, development, and manufacture of immunodiagnostic devices for infectious diseases. As such, we have specifically targeted those diseases that afflict tens of millions of people worldwide. We serve the global public marketplace by providing superior quality products that are accurate, easy to use and cost effective.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.